June 24, 2022
Quotient Limited Announces Proposed Underwritten Offering
JERSEY, Channel Islands, June 23, 2022 (GLOBE NEWSWIRE) — Quotient Limited (Nasdaq: QTNT) (the Company), a commercial-stage diagnostics company, today…
Pharmaceuticals, Biotechnology and Life Sciences
JERSEY, Channel Islands, June 23, 2022 (GLOBE NEWSWIRE) — Quotient Limited (Nasdaq: QTNT) (the Company), a commercial-stage diagnostics company, today…
PORTLAND, Ore., June 23, 2022 (GLOBE NEWSWIRE) — Chalice Brands Ltd. (CSE: CHAL) (OTCQB: CHALF) (the “Company” or “Chalice Brands”),…
— Novel biomarker will be used to identify patients in genetically defined subgroup associated with poorer outcomes — Study will…
Healthcare providers can easily order Myriad’s genetic tests for the more than 250 million patients within Epic’s networkPartnership bolsters Myriad’s…
–NGM621, a monoclonal antibody product candidate engineered to potently inhibit complement C3 for the treatment of patients with geographic atrophy,…
REDWOOD CITY, Calif., June 23, 2022 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology company focused on enabling…
NANTES, France, June 23, 2022 (GLOBE NEWSWIRE) — OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) today announced that all the…
TORONTO, June 22, 2022 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is…
Novartis endorses the Kigali Declaration on neglected tropical diseases, pledging USD 250 million to advance R&D of new treatments against…
Tafinlar + Mekinist, the worldwide targeted therapy leader in BRAF/MEK-inhibition, is the first and only therapy to be approved with…